That is very important, since the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. In other words, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (longtime readers). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough almost no one observed. But it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (longtime readers). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe considerably before going greater - jeff brown stock predictions 2021. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. However that's not the huge question any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown stock predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous excellent personal business on the edge of striking the public markets And I've been dealing with a brand-new way for you to invest even prior to these business go public.
This opportunity has actually been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers understand that tech isn't our normal beat (second wave). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have a number of such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing experts we know (tech stock). In truth, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and predict what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing rapid growth and producing amazing chances for financiers. I want to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown investor prediction. But despite what lots of readers might think, this is a trend that's simply getting going. Even though the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (democratic republic). Losing 2 months of manufacturing and sales really affects the number of 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million systems is remarkable. More significantly, the delays triggered by the pandemic created a lots of suppressed demand. And that need is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - last week. Which's not my only 5G prediction When I've spoken about 5G in the past, I've explained its three various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services begin to be used (brownstone research). That's when we start to see applications operating on 5G networks. Consider things like massive multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not actually appreciate the technology. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open up a suite of unbelievable applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can cause illness. CRISPR can remedy these "typos." For years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were truly only three business operating in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is efficiently a greenfield opportunity.
There's space for many companies to exist in this space. the legacy report predictions. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or 3 more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. But now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug therapies produced using this innovation. This was one of those developments that nearly nobody observed. However it's going to have profound ramifications for treating disease. And, of course, there will be plenty of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back maybe considerably before going greater. I've been covering bitcoin for a long period of time now. One of the first research reports I ever released was on bitcoin - jeff brown genetic sequencer stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. tech stocks. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, but we might not separately verify this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to choose winning technology stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding perspective on the market. He's constantly on the hunt for new opportunities, and he shares numerous of his best choices in the Near Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively anticipated a few of the most significant financial events of the past 20 years. Although he doesn't appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, but Jeff Brown's precise predictions have actually earned him legions of devoted fans. That says a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research study publisher. Brownstone Research study offers numerous research study services with a wide array of specializations - jeff brown latest prediction.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - self-driving cars. On its site, Brownstone says its mission is to offer retail investors with professional-grade research study: "For too long, the very best financial investment research study has not been readily available to private investors. It has actually been typically reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown biotech pick. The objective of Brownstone Research is to make that kind of proprietary research study readily available to any investors seeking to acquire an edge in the markets. The objective is easy to deliver unique and lucrative financial investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise works as the company's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you understand even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. tech stocks. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown thinks S.A.V. what is the legacy report predicting. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two advanced innovations: expert system and electrical vehicles. Musk hopes the combination will help him develop the first fully-autonomous, self-driving automobiles ever. It's nothing short of the automotive industry's Holy Grail. As you know, electrical automobiles and self-driving cars and truck stocks have been big this year, but the Wall Street machine has actually approved hype without much tangible result. Despite a drastic boost in competitors over the past couple of years, Brown still believes Musk has the finest possibility of putting everything together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transport. Generally, this innovation would enable you to lease your car as a self-governing, self-driving taxi when you're not using it. You merely leave the car and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the earnings. It sounds insane, however it might be closed than you believe.